Hasil Pencarian - G. Caleb Alexander

Perbaiki Hasil
  1. 1
    National trends in the ambulatory treatment of hypertension in the United States, 1997-2012.

    National trends in the ambulatory treatment of hypertension in the United States, 1997-2012. oleh Meijia Zhou, Matthew Daubresse, Randall S Stafford, G Caleb Alexander

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis

    Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis oleh Jeffrey R Curtis, G Caleb Alexander, Jiajun Wen, Hanzhe Zhang

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

    Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study oleh G Caleb Alexander, Thomas J Moore, James Heyward, Gerard Anderson

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Promotion of prescription drugs to consumers and providers, 2001-2010.

    Promotion of prescription drugs to consumers and providers, 2001-2010. oleh Rachel Kornfield, Julie Donohue, Ernst R Berndt, G Caleb Alexander

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID‐19: A Retrospective Multicenter Study in the United States

    Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID‐19: A Retrospective Multicenter Study in the United States oleh James M. Stevenson, G. Caleb Alexander, Natasha Palamuttam, Hemalkumar B. Mehta

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.

    Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study. oleh Yunwen Xu, Scott J Pilla, G Caleb Alexander, Irene B Murimi

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Branded prescription drug spending: a framework to evaluate policy options

    Branded prescription drug spending: a framework to evaluate policy options oleh Jeromie Ballreich, G. Caleb Alexander, Mariana Socal, Taruja Karmarkar, Gerard Anderson

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis.

    Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis. oleh James Heyward, Omar Mansour, Lily Olson, Sonal Singh, G Caleb Alexander

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study

    Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study oleh G Caleb Alexander, Thomas J Moore, Stefan P Kruszewski, Phillip W Wirtz

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis

    Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis oleh G Caleb Alexander, Hemalkumar B Mehta, Thomas J Moore, Jodi B Segal

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review

    Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review oleh Thomas Metkus, Jill Curran, Shanshan Lin, Dima M. Qato, G. Caleb Alexander

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis

    Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis oleh G Caleb Alexander, Thomas J Moore, Phillip W Wirtz, Jill N Curran

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study

    Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study oleh Hsien-Yen Chang, Hadi Kharrazi, Dave Bodycombe, Jonathan P. Weiner, G. Caleb Alexander

    Diterbitkan 2018-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs.

    Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs. oleh Irene B Murimi-Worstell, Jeromie M Ballreich, Marissa J Seamans, G Caleb Alexander

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review.

    Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review. oleh Carolyn Tieu, Eleanor J Lucas, Mindi DePaola, Lori Rosman, G Caleb Alexander

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Impact of Race on Classification of Atherosclerotic Risk Using a National Cardiovascular Risk Prediction Tool

    Impact of Race on Classification of Atherosclerotic Risk Using a National Cardiovascular Risk Prediction Tool oleh Jarett R. Beaudoin, MD, MPH, Jill Curran, MS, G. Caleb Alexander, MD, MS

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    The availability of pharmacies in the United States: 2007-2015.

    The availability of pharmacies in the United States: 2007-2015. oleh Dima Mazen Qato, Shannon Zenk, Jocelyn Wilder, Rachel Harrington, Darrell Gaskin, G Caleb Alexander

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Tobacco control policies and smoking cessation treatment utilization: A moderated mediation analysis.

    Tobacco control policies and smoking cessation treatment utilization: A moderated mediation analysis. oleh Johannes Thrul, Kira E Riehm, Joanna E Cohen, G Caleb Alexander, Jon S Vernick, Ramin Mojtabai

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing

    Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing oleh Emma E. McGinty, Elizabeth A. Stuart, G. Caleb Alexander, Colleen L. Barry, Mark C. Bicket, Lainie Rutkow

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease.

    Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease. oleh Sheriza N Baksh, Jodi B Segal, Mara McAdams-DeMarco, Rita R Kalyani, G Caleb Alexander, Stephan Ehrhardt

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: